Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms
Authors
Keywords
-
Journal
SEMINARS IN LIVER DISEASE
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2021-05-16
DOI
10.1055/s-0041-1725022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Towards genetic prediction of non-alcoholic fatty liver disease trajectories: PNPLA3 and beyond
- (2020) Marcin Krawczyk et al. GASTROENTEROLOGY
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Burden of Disease due to Nonalcoholic Fatty Liver Disease
- (2020) Mark D. Muthiah et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease
- (2020) James M. Paik et al. HEPATOLOGY
- Update on NAFLD genetics: from new variants to the clinic
- (2020) Eric Trépo et al. JOURNAL OF HEPATOLOGY
- Natural history of NASH and HCC
- (2020) Francesco Negro LIVER INTERNATIONAL
- Complications, morbidity and mortality of nonalcoholic fatty liver disease
- (2020) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Longitudinal Association of Non‐Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study
- (2020) Lisa B. VanWagner et al. Journal of the American Heart Association
- Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
- (2020) Karthik Chandrasekharan et al. Frontiers in Pharmacology
- Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
- (2020) Rohit Loomba et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology
- (2020) Silvia Sookoian et al. HEPATOLOGY
- Increasing liver fat is associated with progression of cardiovascular risk factors
- (2020) Katherine T. Brunner et al. LIVER INTERNATIONAL
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD and cardiovascular diseases: a clinical review
- (2020) Philipp Kasper et al. Clinical Research in Cardiology
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis
- (2019) Alessandro Mantovani et al. LIVER INTERNATIONAL
- A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
- (2019) Cyrielle Caussy et al. Nature Communications
- Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non‐alcoholic fatty liver disease
- (2019) Joan Khoo et al. LIVER INTERNATIONAL
- The degree of hepatic steatosis associates with impaired cardiac and autonomic function
- (2019) David Houghton et al. JOURNAL OF HEPATOLOGY
- Prescription of statins in suspected non‐alcoholic fatty liver disease and high cardiovascular risk, a population‐based study
- (2019) Eline H. van den Berg et al. LIVER INTERNATIONAL
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
- (2019) Andrew A. Li et al. Gut and Liver
- Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
- (2019) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease
- (2019) Stefania Grimaudo et al. Clinical Gastroenterology and Hepatology
- Editorial: The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis due to NASH
- (2019) Rohit Loomba et al. HEPATOLOGY
- Cardiac abnormalities in patients with nonalcoholic fatty liver disease
- (2019) Yu Dong et al. HERZ
- Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity
- (2019) Ali Aminian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
- (2019) Paul J. Pockros et al. LIVER INTERNATIONAL
- Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
- (2019) Claudio Tana et al. International Journal of Environmental Research and Public Health
- Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease
- (2019) Alina M. Allen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fatty Liver Disease: A Practical Approach
- (2019) Mohamed Mostafa et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
- (2019) Martijn C. G. J. Brouwers et al. DIABETOLOGIA
- Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients
- (2019) Congxiang Shao et al. DIGESTIVE DISEASES AND SCIENCES
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- What’s new in NAFLD pathogenesis, biomarkers and treatment?
- (2019) Christopher D. Byrne et al. Nature Reviews Gastroenterology & Hepatology
- Are Lifestyle Therapies Effective for NAFLD Treatment?
- (2019) Nermeen N. El-Agroudy et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Cardiovascular Risk in NAFLD: An Intimate Relationship?
- (2019) Amedeo Lonardo et al. DIGESTIVE DISEASES AND SCIENCES
- Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
- (2019) Julia Wattacheril GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives
- (2019) Juan P. Arab et al. HEPATOLOGY RESEARCH
- Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease
- (2019) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Evolution of NAFLD and Its Management
- (2019) Manpreet S. Mundi et al. NUTRITION IN CLINICAL PRACTICE
- Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study
- (2018) Antonino Tuttolomondo et al. Cardiovascular Diabetology
- Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2018) Zobair M. Younossi et al. Clinics in Liver Disease
- Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart disease
- (2018) Christopher D Byrne et al. EUROPEAN HEART JOURNAL
- Nonalcoholic fatty liver disease and hypertension
- (2018) Dimitrios Oikonomou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Liver disease and heart failure: Back and forth
- (2018) Michele Correale et al. European Journal of Internal Medicine
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- New insights into NAFLD and subclinical coronary atherosclerosis
- (2018) Lisa B. VanWagner JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
- (2018) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation
- (2018) Ragab A. Mahfouz et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study
- (2018) Yoosoo Chang et al. GUT
- Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
- (2018) Soo Lim et al. Obesity Reviews
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus
- (2017) Kenneth Cusi GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes
- (2017) Yaowu Zou et al. INTERNAL MEDICINE JOURNAL
- Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial
- (2017) Fernando Bril et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes
- (2017) Alessandro Mantovani et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Bi-directional analysis between fatty liver and cardiovascular disease risk factors
- (2017) Jiantao Ma et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study
- (2017) Karlijn J. Nass et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study
- (2017) Lisa B. VanWagner et al. Obesity
- Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery
- (2017) Pierre Eric Danin et al. OBESITY SURGERY
- Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
- (2017) Alessandro Mantovani et al. PLoS One
- Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring
- (2016) Alessandro Mantovani et al. DIABETES CARE
- Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions
- (2016) Kenneth Cusi DIABETOLOGIA
- Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies
- (2016) Daniel Jahn et al. DIGESTIVE DISEASES
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Non-alcoholic fatty liver disease and dyslipidemia: An update
- (2016) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) et al. European Journal of Preventive Cardiology
- Phenotypes of prediabetes and stratification of cardiometabolic risk
- (2016) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- The New Pooled Cohort Equations Risk Calculator
- (2015) David Preiss et al. CANADIAN JOURNAL OF CARDIOLOGY
- Contemporary use of elastography in liver fibrosis and portal hypertension
- (2015) Maja Thiele et al. CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING
- Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2015) Stergios A. Polyzos et al. DIABETOLOGIA
- The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease
- (2015) Daniele Pastori et al. DIGESTIVE AND LIVER DISEASE
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver disease
- (2015) Salvatore Petta et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index
- (2015) Goh Eun Chung et al. MEDICINE
- Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
- (2015) Sheng-Jie Wu et al. MEDICINE
- Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population
- (2015) Yongyuan Zhang et al. BMJ Open
- Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
- (2015) Alessandro Mantovani et al. PLoS One
- Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
- (2014) L. Fedchuk et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study
- (2014) Lisa B. VanWagner et al. ATHEROSCLEROSIS
- Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
- (2014) Yuichiro Eguchi et al. HEPATOLOGY RESEARCH
- Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance
- (2014) María Arias-Loste et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals
- (2014) A. Mantovani et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes
- (2014) Giovanni Targher et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Association between Serum Irisin Levels and Non-Alcoholic Fatty Liver Disease in Health Screen Examinees
- (2014) Eun Sung Choi et al. PLoS One
- Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
- (2014) Stefano Ballestri WORLD JOURNAL OF GASTROENTEROLOGY
- Deterioration of Heart Rate Recovery Index in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2014) Muzaffer Degertekin MEDICAL SCIENCE MONITOR
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- (2013) Ebenezer T. Oni et al. ATHEROSCLEROSIS
- Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with Type 2 diabetes
- (2013) Giovanni Targher et al. CLINICAL SCIENCE
- Interactions of the heart and the liver
- (2013) Søren Møller et al. EUROPEAN HEART JOURNAL
- Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes
- (2013) Maria Boddi et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
- (2013) Stuart McPherson et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
- (2013) Matti J. Tikkanen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
- (2013) Giovanni Targher et al. PLoS One
- Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease
- (2013) Silvia Sookoian et al. PLoS One
- Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability
- (2013) Yu-Chen Liu et al. PLoS One
- Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation
- (2012) Moritz F. Sinner et al. AMERICAN JOURNAL OF CARDIOLOGY
- Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
- (2012) Hideyuki Hyogo et al. DIGESTIVE AND LIVER DISEASE
- Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
- (2012) Shira Zelber-Sagi et al. JOURNAL OF HEPATOLOGY
- The association between fatty liver disease and blood pressure in a population-based cohort study
- (2012) Katharina Lau et al. JOURNAL OF HYPERTENSION
- The Framingham risk score and heart disease in nonalcoholic fatty liver disease
- (2012) Sombat Treeprasertsuk et al. LIVER INTERNATIONAL
- Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
- (2012) David Kleiner et al. SEMINARS IN LIVER DISEASE
- Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
- (2011) S. Bonapace et al. DIABETES CARE
- The Relationship Between Arterial Stiffness and Nonalcoholic Fatty Liver Disease
- (2011) Yong-Jae Lee et al. DIGESTIVE DISEASES AND SCIENCES
- Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis
- (2010) Yusuf Yilmaz et al. ATHEROSCLEROSIS
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Fatty liver incidence and predictive variables
- (2010) Akira Tsuneto et al. HYPERTENSION RESEARCH
- Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
- (2010) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease
- (2009) Julia L. Newton et al. CLINICAL AUTONOMIC RESEARCH
- Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Noreen Hossain et al. Clinical Gastroenterology and Hepatology
- Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
- (2009) Amalia Gastaldelli et al. HEPATOLOGY
- Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
- (2009) Cecilia Söderberg et al. HEPATOLOGY
- Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension
- (2009) F. Fallo et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
- (2008) Anna Ludovica Fracanzani et al. AMERICAN JOURNAL OF MEDICINE
- Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
- (2008) Hyeon Chang Kim et al. ATHEROSCLEROSIS
- Hepatotoxicity of fast food?
- (2008) G. Marchesini et al. GUT
- Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
- (2008) Janus P. Ong et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
- (2008) Silvia Sookoian et al. JOURNAL OF HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started